Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

There are few studies of mobile-Health (mHealth) device application with schizophrenic patients. We aimed to quantitatively assess patient's activity and the relationship between their physical activity and the severity of their psychopathologies. Then we attempted to identify the patients who required intervention and evaluated the feasibility of using the mHealth device. A total of 61 of the 76 available hospitalized patients with chronic schizophrenia who participated in the activity programs were enrolled. They wore a mHealth device for a week to assess their activity (steps/day). The Positive and Negative Syndrome Scale (PANSS) was completed by the subjects. As a result, the positive subscale of the PANSS and the positive and negative factors of the PANSS 5-factor structure showed a predictive value for low levels of physical activity. The group of subjects with a high total PANSS score had a significantly lower level of physical activity than the other groups. In conclusion, physical activity showed a significant association with positive symptoms as well as negative symptoms. The mHealth device showed relatively good feasibility for schizophrenic patients. We should pay more attention to the activity of patients with high PANSS scores.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2016.10.059DOI Listing

Publication Analysis

Top Keywords

mhealth device
20
physical activity
16
activity
9
patients chronic
8
chronic schizophrenia
8
schizophrenic patients
8
positive negative
8
patients
6
mhealth
5
device
5

Similar Publications

Introduction: Cardiovascular disease is a leading global cause of death, with coronary artery disease often requiring coronary artery bypass grafting (CABG). Inadequate rehabilitation increases health risks and costs, and low adherence to center-based rehabilitation has prompted interest in telerehabilitation. Despite technological advances, the global implementation of telerehabilitation for CABG patients remains underexplored.

View Article and Find Full Text PDF

Background: Remote services (in which the patient and staff member are not physically colocated) and digital services (in which a patient encounter is digitally mediated in some way) were introduced extensively when the COVID-19 pandemic began in 2020. We undertook a longitudinal qualitative study of the introduction, embedding, evolution and abandonment of remote and digital innovations in United Kingdom general practice. This synoptic paper summarises study design, methods, key findings, outputs and impacts to date.

View Article and Find Full Text PDF

Cool Solutions in Hot Times: The Case for Digital Health in Heatwave Action Plans.

Online J Public Health Inform

September 2025

CINTESIS@RISE, Centre for Health Technology and Services Research, Faculty of Medicine, University of Porto, Rua Dr. Plácido da Costa, Porto, 4200-450, Portugal, 351 220 426 566.

This viewpoint highlights the critical need for proactive and strategic integration of digital health tools into heat-health action plans (HHAPs) across Europe. Drawing insights from the digital health surge during the COVID-19 pandemic and recent heat-related health impacts, we identify response gaps and suggest specific strategies to strengthen current plans. Key recommendations include leveraging mobile health communication, expanding telemedicine usage, adopting wearable health monitoring devices, and using advanced data analytics to improve responsiveness and equity.

View Article and Find Full Text PDF

Background: Hearing loss affects more than 1.5 billion people worldwide, yet fewer than 10% of those who could benefit from hearing aids are able to access them. Barriers such as high costs, limited availability, and a critical shortage of trained professionals in low- and middle-income countries contribute to this gap, while emerging models of care-such as task-shifting to community healthcare workers (CHWs) supported by mHealth technologies-show promise in improving access, affordability, and outcomes in underserved communities.

View Article and Find Full Text PDF

Introduction: Biofeedback is a non-pharmacological treatment option valued for its minimal risk of adverse events and offers a safe alternative for individuals seeking preventive care for migraine. Despite level A evidence for migraine prevention, biofeedback treatment is still unavailable to most patients. We developed a novel medical device (Cerebri) for multimodal biofeedback treatment that omits the need for healthcare personnel involvement.

View Article and Find Full Text PDF